Albendazole metabolism in patients with neurocysticercosis: antipyrine as a multifunctional marker drug of cytochrome P450
The present study investigates the isoform(s) of cytochrome P450 (CYP) involved in the metabolism of albendazole sulfoxide (ASOX) to albendazole sulfone (ASON) in patients with neurocysticercosis using antipyrine as a multifunctional marker drug. The study was conducted on 11 patients with neurocyst...
Main Authors: | M.P. Marques, O.M. Takayanagui, V.L. Lanchote |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2002-02-01
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2002000200016 |
Similar Items
-
Phenazone (antipyrin)
by: 982 SIRIM -
Severe forms of neurocysticercosis: treatment with albendazole Formas graves da neurocisticercose: tratamento com albendazol
by: Svetlana Agapejev, et al.
Published: (1996-03-01) -
Cytochrome P450 genes expression in human prostate cancer
by: Oksana Maksymchuk, et al.
Published: (2024-03-01) -
Pourradiculoneurite e neurocisticercose: relato de caso Polyradiculoneuropathy and neurocysticercosis: case report
by: Svetlana Agapejev, et al.
Published: (1996-03-01) -
Update on the diagnosis and management of neurocysticercosis
by: Osvaldo Massaiti Takayanagui, et al.
Published: (2022-08-01)